Abstract

Recognition of pathogen-or-damage-associated molecular patterns is critical to inflammation. However, most pathogen-or-damage-associated molecular patterns exist within intact microbes/cells and are typically part of non-diffusible, stable macromolecules that are not optimally immunostimulatory or available for immune detection. Partial digestion of microbes/cells following phagocytosis potentially generates new diffusible pathogen-or-damage-associated molecular patterns, however, our current understanding of phagosomal biology would have these molecules sequestered and destroyed within phagolysosomes. Here, we show the controlled release of partially-digested, soluble material from phagolysosomes of macrophages through transient, iterative fusion-fission events between mature phagolysosomes and the plasma membrane, a process we term eructophagy. Eructophagy is most active in proinflammatory macrophages and further induced by toll like receptor engagement. Eructophagy is mediated by genes encoding proteins required for autophagy and can activate vicinal cells by release of phagolysosomally-processed, partially-digested pathogen associated molecular patterns. We propose that eructophagy allows macrophages to amplify local inflammation through the processing and dissemination of pathogen-or-damage-associated molecular patterns.

The detection of conserved motifs by pattern recognition receptors is a crucial component of the innate detection of pathogens and danger signals via conserved pattern recognition receptors. Here the authors define a pathway that transfers partially digested material from the phagolysosomal pathway of macrophages to release at the plasma membrane which is associated with enhanced inflammatory potential, by a process they introduce as eructophagy.

Details

Title
Macrophages disseminate pathogen associated molecular patterns through the direct extracellular release of the soluble content of their phagolysosomes
Author
Greene, Catherine J. 1 ; Nguyen, Jenny A. 2 ; Cheung, Samuel M. 2 ; Arnold, Corey R. 2 ; Balce, Dale R. 3 ; Wang, Ya Ting 4   VIAFID ORCID Logo  ; Soderholm, Adrian 2 ; McKenna, Neil 2 ; Aggarwal, Devin 2   VIAFID ORCID Logo  ; Campden, Rhiannon I. 5 ; Ewanchuk, Benjamin W. 5 ; Virgin, Herbert W. 6   VIAFID ORCID Logo  ; Yates, Robin M. 7   VIAFID ORCID Logo 

 University of Calgary, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); Washington University School of Medicine, Department of Pathology and Immunology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Vir Biotechnology, San Francisco, USA (GRID:grid.507173.7) 
 Washington University School of Medicine, Department of Pathology and Immunology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002) 
 University of Calgary, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 Washington University School of Medicine, Department of Pathology and Immunology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Vir Biotechnology, San Francisco, USA (GRID:grid.507173.7) 
 University of Calgary, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Snyder Institute of Chronic Disease, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2672488676
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.